Pasar al contenido principal

BASES MOLECULARES Y DETERMINANTES ESTRUCTURALES DE TOXICIDAD CELULAR DE LA AGREGACION AMILOIDE EN LA ENFERMEDAD DE PARKINSON

BFU2015-64119-P

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario UNIVERSIDAD DE ZARAGOZA
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inhibition of α-Synuclein Fibril Elongation by Hsp70 Is Governed by a Kinetic Binding Competition between α-Synuclein Species

  • Aprile, F.A.
  • Arosio, P.
  • Fusco, Giuliana
  • Chen, S.W.
  • Kumita, J.R.
  • Dhulesia, Anne
  • Tortora, P.
  • Knowles, T.P.J.
  • Vendruscolo, M.
  • Dobson, C.M.
  • Cremades, Nunilo
The Hsp70 family of chaperones plays an essential role in suppressing protein aggregation in the cell. Here we investigate the factors controlling the intrinsic ability of human Hsp70 to inhibit the elongation of amyloid fibrils formed by the Parkinson's disease-related protein α-synuclein. Using kinetic analysis, we show that Hsp70 binds preferentially to α-synuclein fibrils as a consequence of variations in the association and dissociation rate constants of binding to the different aggregated states of the protein. Our findings illustrate the importance of the kinetics of binding of molecular chaperones, and also of potential therapeutic molecules, in the efficient suppression of specific pathogenic events linked to neurodegeneration., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multiplicity of α-synuclein aggregated species and their possible roles in disease

  • Gracia, Pablo
  • Camino, José D.
  • Volpicelli-Daley, Laura
  • Cremades, Nunilo
27 pags., 4 figs., α-Synuclein amyloid aggregation is a defining molecular feature of Parkinson’s disease, Lewy body dementia, and multiple system atrophy, but can also be found in other neurodegenerative disorders such as Alzheimer’s disease. The process of α-synuclein aggregation can be initiated through alternative nucleation mechanisms and dominated by different secondary processes giving rise to multiple amyloid polymorphs and intermediate species. Some aggregated species have more inherent abilities to induce cellular stress and toxicity, while others seem to be more potent in propagating neurodegeneration. The preference for particular types of polymorphs depends on the solution conditions and the cellular microenvironment that the protein encounters, which is likely related to the distinct cellular locations of α-synuclein inclusions in different synucleinopathies, and the existence of disease-specific amyloid polymorphs. In this review, we discuss our current understanding on the nature and structure of the various types of α-synuclein aggregated species and their possible roles in pathology. Precisely defining these distinct α-synuclein species will contribute to understanding the molecular origins of these disorders, developing accurate diagnoses, and designing effective therapeutic interventions for these highly debilitating neurodegenerative diseases., This research was funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), grant number BFU2015-64119-P (N.C.), the Spanish Ministry of Science, Innovation and Universities (MICIU) and the European Commission (FEDER), grant number PGC2018-096335-B-100 (N.C.), and the National Institute of Neurological Disorders and Stroke (NINDS) of the National Health Institute (NIH), grant number R01NS102257) (L.V.-D.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The role of water in the primary nucleation of protein amyloid aggregation

  • Camino, José D.
  • Gracia, Pablo
  • Cremades, Nunilo
10 pags, 1 fig., The understanding of the complex conformational landscape of amyloid aggregation and its modulation by relevant physicochemical and cellular factors is a prerequisite for elucidating some of the molecular basis of pathology in amyloid related diseases, and for developing and evaluating effective disease-specific therapeutics to reduce or eliminate the underlying sources of toxicity in these diseases. Interactions of proteins with solvating water have been long considered to be fundamental in mediating their function and folding; however, the relevance of water in the process of protein amyloid aggregation has been largely overlooked. Here, we provide a perspective on the role water plays in triggering primary amyloid nucleation of intrinsically disordered proteins (IDPs) based on recent experimental evidences. The initiation of amyloid aggregation likely results from the synergistic effect between both protein intermolecular interactions and the properties of the water hydration layer of the protein surface. While the self-assembly of both hydrophobic and hydrophilic IDPs would be thermodynamically favoured due to large water entropy contributions, large desolvation energy barriers are expected, particularly for the nucleation of hydrophilic IDPs. Under highly hydrating conditions, primary nucleation is slow, being facilitated by the presence of nucleation-active surfaces (heterogeneous nucleation). Under conditions of poor water activity, such as those found in the interior of protein droplets generated by liquid-liquid phase separation, however, the desolvation energy barrier is significantly reduced, and nucleation can occur very rapidly in the bulk of the solution (homogeneous nucleation), giving rise to structurally distinct amyloid polymorphs. Water, therefore, plays a key role in modulating the transition free energy of amyloid nucleation, thus governing the initiation of the process, and dictating the type of preferred primary nucleation and the type of amyloid polymorph generated, which could vary depending on the particular microenvironment that the protein molecules encounter in the cell., The authors acknowledge financial support from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), the Spanish Ministry of Science, Innovation and Universities (MICIU) and the European Commission (FEDER) (Grants RYC-2012- 12068, BFU2015-64119-P and PGC2018-096335-B-100).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

  • Santos, Jaime
  • Gracia, Pablo
  • Navarro, Susanna
  • Peña-Díaz, Samuel
  • Pujols, Jordi
  • Cremades, Nunilo
  • Pallarés, Irantzu
  • Ventura, Salvador
14 pags., 6 figs., α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson’s disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of α-helical peptides that bind to these α-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic α-synuclein species., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) BIO2016-78310-R and BIO2017-91475-EXP to S.V, by the Ministry of Science and Innovation (MICINN) PID2019-105017RB-I00 to S.V, by ICREA, ICREA-Academia 2015 to S.V. N.C. was supported by MINECO RYC-2012-12068, MINECO/FEDER, EU BFU2015-64119-P and MICIU/FEDER, EU PGC2018-096335-B-100. J.S. was supported by MICINN via a doctoral grant (FPU17/01157).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells

  • Cascella, Roberta
  • Chen, Serene W.
  • Bigi, A.
  • Camino, José D.
  • Xu, C.K.
  • Dobson, Christopher M.
  • Chiti, Fabrizio
  • Cremades, Nunilo
  • Cecchi, Cristina
16 pags., 6 figs., The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key characteristic of Parkinson’s disease. To define the nature of the species giving rise to neuronal damage, we have investigated the mechanism of action of the main αS populations that have been observed to form progressively during fibril growth. The αS fibrils release soluble prefibrillar oligomeric species with cross-β structure and solvent-exposed hydrophobic clusters. αS prefibrillar oligomers are efficient in crossing and permeabilize neuronal membranes, causing cellular insults. Short fibrils are more neurotoxic than long fibrils due to the higher proportion of fibrillar ends, resulting in a rapid release of oligomers. The kinetics of released αS oligomers match the observed kinetics of toxicity in cellular systems. In addition to previous evidence that αS fibrils can spread in different brain areas, our in vitro results reveal that αS fibrils can also release oligomeric species responsible for an immediate dysfunction of the neurons in the vicinity of these species., This research was supported by the University of Florence (Fondi Ateneo to F.C. and C.C.), the Ministry of Education, Universities and Research of Italy (Progetto Dipartimento di Eccellenza “Gender Medicine” to C.C.), Parkinson’s UK (G-1508 to S.W.C. and C.M.D.), the Center for Misfolding Diseases of the University of Cambridge (S.W.C. and C.M.D.), the UK Medical Research Council (MR/N000676/1 to C.M.D.), the Agency of Science, Technology and Research of Singapore (to S.W.C.), and the Ministry of Economy and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BFU2015-64119-P to N.C.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells

  • Cascella, Roberta
  • Chen, Serene W.
  • Bigi, A.
  • Camino, José D.
  • Xu, C.K.
  • Dobson, Christopher M.
  • Chiti, Fabrizio
  • Cremades, Nunilo
  • Cecchi, Cristina
16 pags., 6 figs. -- Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41467-021-21937-3, The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key characteristic of Parkinson’s disease. To define the nature of the species giving rise to neuronal damage, we have investigated the mechanism of action of the main αS populations that have been observed to form progressively during fibril growth. The αS fibrils release soluble prefibrillar oligomeric species with cross-β structure and solvent-exposed hydrophobic clusters. αS prefibrillar oligomers are efficient in crossing and permeabilize neuronal membranes, causing cellular insults. Short fibrils are more neurotoxic than long fibrils due to the higher proportion of fibrillar ends, resulting in a rapid release of oligomers. The kinetics of released αS oligomers match the observed kinetics of toxicity in cellular systems. In addition to previous evidence that αS fibrils can spread in different brain areas, our in vitro results reveal that αS fibrils can also release oligomeric species responsible for an immediate dysfunction of the neurons in the vicinity of these species., This research was supported by the University of Florence (Fondi Ateneo to F.C. and C.C.), the Ministry of Education, Universities and Research of Italy (Progetto Dipartimento di Eccellenza “Gender Medicine” to C.C.), Parkinson’s UK (G-1508 to S.W.C. and C.M.D.), the Center for Misfolding Diseases of the University of Cambridge (S.W.C. and C.M.D.), the UK Medical Research Council (MR/N000676/1 to C.M.D.), the Agency of Science, Technology and Research of Singapore (to S.W.C.), and the Ministry of Economy and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BFU2015-64119-P to N.C.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells

  • Cascella, Roberta
  • Chen, Serene W.
  • Bigi, A.
  • Camino, José D.
  • Xu, C.K.
  • Dobson, Christopher M.
  • Chiti, Fabrizio
  • Cremades, Nunilo
  • Cecchi, Cristina
16 pags., 6 figs. -- The online version contains supplementary material available at https://doi.org/10.1038/s41467-021-21937-3, The self-assembly of α-synuclein (αS) into intraneuronal inclusion bodies is a key characteristic of Parkinson’s disease. To define the nature of the species giving rise to neuronal damage, we have investigated the mechanism of action of the main αS populations that have been observed to form progressively during fibril growth. The αS fibrils release soluble prefibrillar oligomeric species with cross-β structure and solvent-exposed hydrophobic clusters. αS prefibrillar oligomers are efficient in crossing and permeabilize neuronal membranes, causing cellular insults. Short fibrils are more neurotoxic than long fibrils due to the higher proportion of fibrillar ends, resulting in a rapid release of oligomers. The kinetics of released αS oligomers match the observed kinetics of toxicity in cellular systems. In addition to previous evidence that αS fibrils can spread in different brain areas, our in vitro results reveal that αS fibrils can also release oligomeric species responsible for an immediate dysfunction of the neurons in the vicinity of these species., This research was supported by the University of Florence (Fondi Ateneo to F.C. and C.C.), the Ministry of Education, Universities and Research of Italy (Progetto Dipartimento di Eccellenza “Gender Medicine” to C.C.), Parkinson’s UK (G-1508 to S.W.C. and C.M.D.), the Center for Misfolding Diseases of the University of Cambridge (S.W.C. and C.M.D.), the UK Medical Research Council (MR/N000676/1 to C.M.D.), the Agency of Science, Technology and Research of Singapore (to S.W.C.), and the Ministry of Economy and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BFU2015-64119-P to N.C.).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The extent of protein hydration dictates the preference for heterogeneous or homogeneous nucleation generating either parallel or antiparallel ß-sheet a-synuclein aggregates

  • Camino, J.D.
  • Gracia, P.
  • Chen, S.W.
  • Sot, J.
  • De La Arada, I.
  • Sebastián, V.
  • Arrondo, J.L.R.
  • Goñi, F.M.
  • Dobson, C.M.
  • Cremades, N.
a-Synuclein amyloid self-assembly is the hallmark of a number of neurodegenerative disorders, including Parkinson 's disease, although there is still very limited understanding about the factors and mechanisms that trigger this process. Primary nucleation has been observed to be initiated in vitro at hydrophobic/hydrophilic interfaces by heterogeneous nucleation generating parallel ß-sheet aggregates, although no such interfaces have yet been identified in vivo. In this work, we have discovered that a-synuclein can self-assemble into amyloid aggregates by homogeneous nucleation, without the need of an active surface, and with a preference for an antiparallel ß-sheet arrangement. This particular structure has been previously proposed to be distinctive of stable toxic oligomers and we here demonstrate that it indeed represents the most stable structure of the preferred amyloid pathway triggered by homogeneous nucleation under limited hydration conditions, including those encountered inside a-synuclein droplets generated by liquid-liquid phase separation. In addition, our results highlight the key role that water plays not only in modulating the transition free energy of amyloid nucleation, and thus governing the initiation of the process, but also in dictating the type of preferred primary nucleation and the type of amyloid polymorph generated depending on the extent of protein hydration. These findings are particularly relevant in the context of in vivo a-synuclein aggregation where the protein can encounter a variety of hydration conditions in different cellular microenvironments, including the vicinity of lipid membranes or the interior of membraneless compartments, which could lead to the formation of remarkably different amyloid polymorphs by either heterogeneous or homogeneous nucleation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

Multiplicity of a-synuclein aggregated species and their possible roles in disease

  • Gracia, P.
  • Camino, J.D.
  • Volpicelli-Daley, L.
  • Cremades, N.
a-Synuclein amyloid aggregation is a defining molecular feature of Parkinson’s disease, Lewy body dementia, and multiple system atrophy, but can also be found in other neurodegenerative disorders such as Alzheimer’s disease. The process of a-synuclein aggregation can be initiated through alternative nucleation mechanisms and dominated by different secondary processes giving rise to multiple amyloid polymorphs and intermediate species. Some aggregated species have more inherent abilities to induce cellular stress and toxicity, while others seem to be more potent in propagating neurodegeneration. The preference for particular types of polymorphs depends on the solution conditions and the cellular microenvironment that the protein encounters, which is likely related to the distinct cellular locations of a-synuclein inclusions in different synucleinopathies, and the existence of disease-specific amyloid polymorphs. In this review, we discuss our current understanding on the nature and structure of the various types of a-synuclein aggregated species and their possible roles in pathology. Precisely defining these distinct a-synuclein species will contribute to understanding the molecular origins of these disorders, developing accurate diagnoses, and designing effective therapeutic interventions for these highly debilitating neurodegenerative diseases.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The role of water in the primary nucleation of protein amyloid aggregation

  • Camino, J.D.
  • Gracia, P.
  • Cremades, N.
The understanding of the complex conformational landscape of amyloid aggregation and its modulation by relevant physicochemical and cellular factors is a prerequisite for elucidating some of the molecular basis of pathology in amyloid related diseases, and for developing and evaluating effective disease-specific therapeutics to reduce or eliminate the underlying sources of toxicity in these diseases. Interactions of proteins with solvating water have been long considered to be fundamental in mediating their function and folding; however, the relevance of water in the process of protein amyloid aggregation has been largely overlooked. Here, we provide a perspective on the role water plays in triggering primary amyloid nucleation of intrinsically disordered proteins (IDPs) based on recent experimental evidences. The initiation of amyloid aggregation likely results from the synergistic effect between both protein intermolecular interactions and the properties of the water hydration layer of the protein surface. While the self-assembly of both hydrophobic and hydrophilic IDPs would be thermodynamically favoured due to large water entropy contributions, large desolvation energy barriers are expected, particularly for the nucleation of hydrophilic IDPs. Under highly hydrating conditions, primary nucleation is slow, being facilitated by the presence of nucleation-active surfaces (heterogeneous nucleation). Under conditions of poor water activity, such as those found in the interior of protein droplets generated by liquid-liquid phase separation, however, the desolvation energy barrier is significantly reduced, and nucleation can occur very rapidly in the bulk of the solution (homogeneous nucleation), giving rise to structurally distinct amyloid polymorphs. Water, therefore, plays a key role in modulating the transition free energy of amyloid nucleation, thus governing the initiation of the process, and dictating the type of preferred primary nucleation and the type of amyloid polymorph generated, which could vary depending on the particular microenvironment that the protein molecules encounter in the cell.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

a-Helical peptidic scaffolds to target a-synuclein toxic species with nanomolar affinity

  • Santos, J.
  • Gracia, P.
  • Navarro, S.
  • Peña-Díaz, S.
  • Pujols, J.
  • Cremades, N.
  • Pallarès, I.
  • Ventura, S.
a-Synuclein aggregation is a key driver of neurodegeneration in Parkinson’s disease and related syndromes. Accordingly, obtaining a molecule that targets a-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of a-helical peptides that bind to these a-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic a-synuclein species. © 2021, The Author(s).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Gracia González, Pablo
  • Navarro, Susanna|||0000-0001-8160-9536
  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Cremades, Nunilo|||0000-0002-9138-6687
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson's disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of α-helical peptides that bind to these α-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic α-synuclein species. α-Synuclein (αS) aggregation is a driver of several neurodegenerative disorders. Here, the authors identify a class of peptides that bind toxic αS oligomers and amyloid fibrils but not monomeric functional protein, and prevent further αS aggregation and associated cell damage.